Teva's Surprising Choice of Chairman May Be Short-term Fix

Yitzhak Peterburg's appointment to chair big pharma firm follows rejection from overseas candidates.

comments Print
Last week’s appointment of Yitzhak Peterburg as the new chairman of the board at Teva Pharmaceutical Industries, replacing Phillip Frost, was surprising for a number of reasons.